Innealta Capital’s Lifestance Health LFST Stock Holding History

Innealta Capital’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,224	Closed	-$15.8K	–	998
2024 Q2	$15.8K	Buy	+3,224	New	+$19.4K	0.01%	733

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Innealta Capital's LFST Position: Q3 2024 in Review

Innealta Capital sold out of Lifestance Health (LFST) in Q3 2024, closing a stake of 3,224 shares — an estimated $15.8K sold.

Innealta Capital first reported a position in LFST in Q2 2024 and held it in 1 quarter. The position peaked at $15.8K in Q2 2024. 130 funds tracked by Wall St. Rank hold LFST as of Q3 2024.

Innealta Capital reported no remaining Lifestance Health position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 3,224 Lifestance Health shares in Q3 2024, an estimated $15.8K.
Innealta Capital first reported a position in Lifestance Health in Q2 2024 and held it in 1 quarter.
Innealta Capital's Lifestance Health position peaked at $15.8K in Q2 2024.
130 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.